Publications by authors named "Carlos Eduardo Contreras-Garcia"
Article Synopsis
- Intravenous immunoglobulin (IVIG) is commonly used to treat humoral primary immunodeficiency diseases (PIDs), but about one-third of patients experience adverse reactions, including kidney issues.
- A study conducted on patients receiving IVIG at a specialized clinic in Mexico City revealed that 51.4% of participants showed signs of kidney damage, particularly those who had been treated for over 5 years.
- The findings highlight the importance of regular kidney function evaluations for these patients and suggest using sugar-free immunoglobulin to mitigate risks of chronic kidney disease (CKD).
[Association between metabolic syndrome and breast cancer].
Carlos Eduardo Contreras-García Luis Alberto Guizar-García Maura Estela Noyola-García Juan Carlos Anda-Garay
Rev Med Inst Mex Seguro Soc
April 2020
Metabolic syndrome is a set of risk factors associated with cardiovascular disease and diabetes. In Mexico, its prevalence has been reported up to 49.8%, significantly higher than in other countries.
View Article and Find Full Text PDFBackground: Community-acquired pneumonia is an important cause of mortality and morbidity worldwide. Therefore, our aim was to assess the efficacy and safety of outpatient treatment of community-acquired pneumonia.
Methods: We systematically reviewed randomized clinical trials evaluating efficacy and safety of outpatient treatment (OPT) compared with inpatient treatment (IPT) of community-acquired pneumonia in patients without added co-morbidity.